Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
10:14:00 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1200 AUD | 0.00% |
|
-7.69% | -20.00% |
| Market Cap | 61.6M 44.18M 38.06M 36.04M 32.67M 61.29M 4.22B 428M 165M 2.15B 166M 162M 6.79B | P/E 2027 * |
-5.22x | P/E 2028 * | -17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 43.7M 31.34M 27M 25.57M 23.17M 43.48M 2.99B 304M 117M 1.52B 118M 115M 4.81B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.02x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATX | Delayed | |
OTC Markets
| INNMF | Delayed |
| 1 week | -7.69% | ||
| Current month | -11.11% | ||
| 1 month | -14.29% | ||
| 3 months | +9.09% | ||
| 6 months | +4.35% | ||
| Current year | -20.00% |
| 1 week | 0.12 |  | 0.14 |
| 1 month | 0.12 | | 0.16 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/12/2022 | |
Hamish George
DFI | Director of Finance/CFO | - | 01/10/2021 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 02/09/2015 |
Warwick Tong
CHM | Chairman | - | 25/05/2018 |
Jane Bell
CHM | Chairman | - | 30/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/09/25 | Buy | Chairman | 336,826 | 0.0868% | ||
| 08/09/25 | Exercice | Chairman | 750,000 | 0.1933% | ||
| 08/09/25 | Free | Founder | 447,000 | 0.1152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -7.69% | -27.27% | +48.15% | 44.18M | |
| -2.11% | -1.68% | +43.40% | +95.27% | 66.93B | |
| -0.23% | -4.45% | +32.50% | +75.75% | 61.97B | |
| +1.67% | +2.47% | -11.32% | +380.54% | 28.26B | |
| -1.05% | -4.43% | +28.84% | +10.59% | 24.59B | |
| +0.34% | -6.78% | -0.01% | -16.35% | 24.3B | |
| +0.43% | -3.37% | +16.22% | -17.99% | 19.41B | |
| -3.03% | -2.29% | +181.72% | +335.27% | 16.77B | |
| -1.94% | -4.94% | -8.15% | +483.69% | 14.18B | |
| +3.24% | -0.31% | -7.34% | +880.45% | 14B | |
| Average | -0.27% | -3.42% | +24.86% | +227.54% | 27.05B | |
| Weighted average by Cap. | -0.56% | -2.83% | +31.25% | +170.63% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.81M 5.87M 5.56M 5.04M 9.45M 651M 66.02M 25.39M 331M 25.59M 25.03M 1.05B |
| Net income | -11.6M -8.32M -7.17M -6.79M -6.15M -11.54M -795M -80.61M -31M -404M -31.25M -30.56M -1.28B | -4.1M -2.94M -2.53M -2.4M -2.17M -4.08M -281M -28.49M -10.96M -143M -11.04M -10.8M -452M |
| Net Debt | -17.9M -12.84M -11.06M -10.47M -9.49M -17.81M -1.23B -124M -47.83M -624M -48.21M -47.16M -1.97B | -23.4M -16.78M -14.46M -13.69M -12.41M -23.28M -1.6B -163M -62.53M -816M -63.03M -61.65M -2.58B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | A$0.1200 | 0.00% | 916,457 |
| 10/09/26 | A$0.1200 | -7.69% | 521,229 |
| 09/09/26 | A$0.1300 | 0.00% | 448,319 |
| 08/09/26 | A$0.1300 | 0.00% | 1,040,026 |
| 07/09/26 | A$0.1300 | 0.00% | 32,102 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1200AUD
Average target price
0.4200AUD
Spread / Average Target
+250.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
